Form D · Biotechnology
LungLife AI, Inc.
Thousand Oaks, CA · CIK 0001445789
Offering snapshot reported Mar 22, 2024 · SEC filing
- Reported sold
- $316K Offering amount: $316K
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 22, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 22, 2024 | Initial | $315,780 | No comparison | 8 | SEC filing |
| Jul 16, 2021 | Initial | $6,076,213 | No comparison | Not reported | SEC filing |
| Jul 16, 2021 | Initial | $1,083,905 | No comparison | Not reported | SEC filing |
| Jul 15, 2021 | Initial | $2,844,999 | No comparison | Not reported | SEC filing |
| May 26, 2021 | Amendment | $10,246,366 | $2,402,242vs Mar 19, 2020 | 35 | SEC filing |
| Dec 7, 2020 | Initial | $90,000 | No comparison | 1 | SEC filing |
| Mar 19, 2020 | Amendment | $7,844,124 | $1,279,413vs Oct 29, 2019 | 35 | SEC filing |
| Oct 29, 2019 | Amendment | $6,564,711 | $847,548vs Sep 5, 2019 | 35 | SEC filing |
| Sep 5, 2019 | Amendment | $5,717,163 | $1,416,956vs Apr 1, 2019 | 35 | SEC filing |
| Apr 1, 2019 | Amendment | $4,300,207 | $500,000vs Jan 18, 2019 | 2 | SEC filing |
| Jan 18, 2019 | Amendment | $3,800,207 | $168,559vs Jan 17, 2019 | 5 | SEC filing |
| Jan 17, 2019 | Amendment | $3,631,648 | $1,457,896vs Nov 13, 2017 | 15 | SEC filing |
| Nov 13, 2017 | Amendment | $2,173,752 | $417,671vs Oct 31, 2017 | 3 | SEC filing |
| Oct 31, 2017 | Initial | $1,756,081 | No comparison | 29 | SEC filing |
| Jun 4, 2015 | Initial | $25,426,258 | No comparison | 41 | SEC filing |
| Sep 2, 2014 | Amendment | $3,000,000 | $1,000,000vs Jul 29, 2014 | 23 | SEC filing |
| Jul 29, 2014 | Amendment | $2,000,000 | $217,155vs Jul 15, 2014 | 2 | SEC filing |
| Jul 15, 2014 | Initial | $1,782,845 | No comparison | 29 | SEC filing |
| Jan 28, 2014 | Amendment | $1,482,979 | $53,190vs Dec 4, 2013 | 3 | SEC filing |
| Dec 4, 2013 | Initial | $1,429,789 | No comparison | 17 | SEC filing |
| Nov 25, 2013 | Initial | $3,284,704 | No comparison | 25 | SEC filing |
| Oct 18, 2013 | Amendment | $3,202,814 | $650,000vs Oct 9, 2013 | 2 | SEC filing |
| Oct 9, 2013 | Amendment | $2,552,814 | $200,000vs Oct 8, 2013 | 1 | SEC filing |
| Oct 8, 2013 | Amendment | $2,352,814 | $400,000vs Aug 8, 2013 | 2 | SEC filing |
| Aug 8, 2013 | Amendment | $1,952,814 | $196,745vs Jul 12, 2013 | 5 | SEC filing |
| Jul 12, 2013 | Initial | $1,756,069 | No comparison | 21 | SEC filing |
| Nov 26, 2012 | Amendment | $2,992,665 | $787,863vs Nov 8, 2012 | 15 | SEC filing |
| Nov 8, 2012 | Amendment | $2,204,802 | $204,802vs Aug 1, 2012 | 7 | SEC filing |
| Aug 1, 2012 | Amendment | $2,000,000 | $759,220vs Jul 25, 2012 | 3 | SEC filing |
| Jul 25, 2012 | Initial | $1,240,780 | No comparison | 22 | SEC filing |
| May 7, 2012 | Amendment | $2,650,000 | $1,430,000vs Dec 5, 2011 | 25 | SEC filing |
| Dec 5, 2011 | Amendment | $1,220,000 | $720,000vs Nov 29, 2011 | 12 | SEC filing |
| Nov 29, 2011 | Initial | $500,000 | No comparison | 1 | SEC filing |
| Nov 29, 2011 | Initial | $1,966,802 | No comparison | 16 | SEC filing |
| May 24, 2011 | Amendment | $1,605,334 | $500,000vs Nov 2, 2010 | 1 | SEC filing |
| May 24, 2011 | Amendment | $1,866,334 | $261,000vs May 24, 2011 | 3 | SEC filing |
| Nov 2, 2010 | Amendment | $1,105,334 | $624,928vs Aug 30, 2010 | 4 | SEC filing |
| Aug 30, 2010 | Amendment | $480,406 | $120,406vs Aug 11, 2010 | 4 | SEC filing |
| Aug 11, 2010 | Initial | $360,000 | No comparison | 6 | SEC filing |
| Jan 11, 2010 | Initial | $1,968,783 | No comparison | 1 | SEC filing |
| Dec 17, 2009 | Amendment | $1,718,783 | $50,000vs Nov 24, 2009 | 2 | SEC filing |
| Nov 24, 2009 | Amendment | $1,668,783 | $170,000vs Nov 12, 2009 | 5 | SEC filing |
| Nov 12, 2009 | Amendment | $1,498,783 | $195,000vs Sep 29, 2009 | 4 | SEC filing |
| Sep 29, 2009 | Amendment | $1,303,783 | $119,142vs Aug 12, 2009 | 4 | SEC filing |
| Aug 12, 2009 | Amendment | $1,184,641 | $160,156vs Jun 4, 2009 | 5 | SEC filing |
| Jun 4, 2009 | Initial | $1,024,485 | No comparison | Not reported | SEC filing |
| Sep 17, 2008 | Paper | Not reported | No comparison | Not reported |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-508428
Source: Form D, filed Mar 22, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Anderson | Director, Executive |
| Paul Anderson | Director, Executive |
| Sara Barrington | Director |
| Paul Billings | Director |
| Scott Bogart | Executive |
| Andrew Boteler | Director |
| Gordon Roy Davis | Director |
| Roy Davis | Director |
| Andre De Fusco | Director, Executive |
| Daotian Fu | Director |
| Daotian Fu, Ph.D | Director |
| Andre De Fusco | Director, Executive |
| Andre De Fusco | Director, Executive |
| Harry Gelles | Director |
| Frederick Gluck | Director |
| Alan Heeger | Director |
| Jeffrey Kob | Director |
| Jianing Liu | Director |
| James Mc Cullough | Director |
| Paul Meyer | Executive |
| Amit Munshi | Director |
| Paul Pagano | Director, Executive |
| Yu Cai Peng, Ph.D | Director |
| Michael Pfau | Executive |
| Simon Raab | Director |
| Tom Hyhongsok Soh | Director |
| Tom Hyongsok Soh | Director |
| Dennis Stubblefield | Director |
| Dennis Stuffblefie | Director |
| Justin Xiang | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2545 W. Hillcrest Drive, Suite 140
Thousand Oaks, CA, 91320
Thousand Oaks, CA, 91320